Insulin Glargine (Lantus) Injectable Suppliers & Bulk Manufacturers

Available Forms: Vials/pens

Available Strengths: U-100, U-300

Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)

Category: Diabetes

Insulin Glargine (Lantus) provides a steady, long-lasting release of insulin, mimicking natural basal insulin to regulate blood sugar levels throughout the day. Its benefits include consistent glucose control, reduced risk of hypoglycemia, and improved insulin adherence, making it effective for managing both type 1 and type 2 diabetes. Insulin Glargine (Lantus) injectable is available in Vials/pens and strengths such as U-100, U-300. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Insulin Glargine (Lantus) injectable is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Insulin Glargine (Lantus) injectable can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Insulin Glargine (Lantus) is a long-acting basal insulin approved in the EU and US for managing diabetes. In the EU, it is regulated by the EMA, with Sanofi’s Lantus and Toujeo holding approved dossiers demonstrating safety and efficacy. In the US, the FDA approved Lantus and biosimilars like Basaglar, based on comprehensive clinical data and biosimilarity studies. Both regions require detailed dossiers and ongoing pharmacovigilance for post-marketing surveillance. For expert support with regulatory dossiers and compliance, visit PharmaTradz, your trusted partner in pharmaceutical regulatory services.